Samuel C. Blackman insider trades
Open-market stock purchases and sales by Samuel C. Blackman, HEAD OF R&D at Day One Biopharmaceuticals, Inc, from SEC Form 4 filings since Oct 22, 2021.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- DAWN Day One Biopharmaceuticals, Inc: 44 sales, last Dec 10, 2024